Enzalutamide: Difference between revisions
Jump to navigation
Jump to search
Created page with "'''Enzalutamide''' is an antrogen receptor antagonist used to treat prostate cancer.<ref name=pmid23887973>{{Cite journal | last1 = Mitsiades | first1 = N. | title = A ro..." |
|||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''Enzalutamide''' is an | '''Enzalutamide''' is an [[androgen receptor]] antagonist used to treat [[prostate cancer]].<ref name=pmid23887973>{{Cite journal | last1 = Mitsiades | first1 = N. | title = A road map to comprehensive androgen receptor axis targeting for castration-resistant prostate cancer. | journal = Cancer Res | volume = 73 | issue = 15 | pages = 4599-605 | month = Aug | year = 2013 | doi = 10.1158/0008-5472.CAN-12-4414 | PMID = 23887973 }}</ref> | ||
==See also== | ==See also== | ||
*[[Abiraterone]]. | *[[Abiraterone]]. | ||
*[[Androgen receptor]]. | |||
==References== | ==References== | ||
| Line 8: | Line 9: | ||
[[Category:Clinical]] | [[Category:Clinical]] | ||
[[Category:Drugs]] | |||